HIV & AIDS

Special antibodies could lead to HIV vaccine

Around one percent of people infected with HIV produce antibodies that block most strains of the virus. These broadly acting antibodies provide the key to developing an effective vaccine against HIV. Researchers from the ...

HIV & AIDS

Researchers date 'hibernating' HIV strains

Researchers at the BC Centre for Excellence in HIV/AIDS (BC-CfE) and Simon Fraser University (SFU), in partnership with University of British Columbia (UBC) and Western University, have developed a novel way for dating "hibernating" ...

HIV & AIDS

How does HIV escape cellular booby traps?

HIV is believed to have evolved from a simian immunodeficiency virus, or SIV, that originated in chimpanzees. How SIV made the species jump has remained a mystery, since humans possess a defense mechanism that should prevent ...

Diseases, Conditions, Syndromes

New molecule shows promise in HIV vaccine design

Researchers at the University of Maryland and Duke University have designed a novel protein-sugar vaccine candidate that, in an animal model, stimulated an immune response against sugars that form a protective shield around ...

HIV & AIDS

Three-in-one antibody protects monkeys from HIV-like virus

A three-pronged antibody made in the laboratory protected monkeys from infection with two strains of SHIV, a monkey form of HIV, better than individual natural antibodies from which the engineered antibody is derived, researchers ...

HIV & AIDS

UN warns of growing resistance to AIDS drugs

Countries must halt the rise of AIDS drug resistance to prevent a swell in new infections and deaths and spiralling treatment cost, the UN's health agency warned Thursday.

page 2 from 8